Moderately differentiated pancreatic cancer refers to pancreatic cancer cells that are moderately differentiated and is commonly used to determine the prognosis of pancreatic cancer. Pancreatic cancer is a malignant tumor caused by uncontrolled growth of pancreatic cells, and the occurrence of this disease is associated with long-term smoking, obesity, chronic pancreatitis and other factors. Through pathological examination of cancerous tissues, tumor cells can be classified into three levels according to their degree of differentiation, i.e., highly differentiated, moderately differentiated, and lowly differentiated. The lower the differentiation, the greater the difference with normal cells and the worse the prognosis. Treatment after diagnosis includes surgical resection, radiation therapy, chemotherapy, immunotherapy, interventional therapy, and supportive therapy. If regular treatment is received in a timely manner, about 15-20% of patients can survive for a long time, with an average survival time of about 15-24 months.